Skyhawk Therapeutics
Drug Discovery

Skyhawk Therapeutics: Products & infrastructure

Skyhawk Therapeutics has 3 clinical trials on record, 3 under way.

Data updated Nov 22, 2026 · Back to the company report

Products

Skyhawk Therapeutics has 3 clinical trials on record, 3 under way.

3clinical trials
3trials under way
3in phase 3
1EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A Phase 2/3 Randomized, Double Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Pharmacodynamics, Safety a…
Phase II and Phase III (Integrated) · Huntington’s Disease · Germany, Spain
Jul 2026
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
An Extension of SKY-0515 in Participants With Huntington's Disease
phase 3 · under way · 500 participants · Huntington's Disease (HD)
Apr 2026
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
phase 3 · under way · 400 participants · Huntington Disease
Jan 2026
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
phase 3 · under way · 120 participants · Huntington Disease; Huntingtons Disease
May 2025
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.